Research ArticleSpecial Contributions
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra and Gary S. Dorfman
Journal of Nuclear Medicine June 2015, 56 (6) 955-961; DOI: https://doi.org/10.2967/jnumed.115.158402
Michael M. Graham
1Division of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Richard L. Wahl
2Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
John M. Hoffman
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Jeffrey T. Yap
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
John J. Sunderland
1Division of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Ronald Boellaard
4Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands
Eric S. Perlman
5Perlman Advisory Group, LLC, Hillsdale, New York
Paul E. Kinahan
6Department of Radiology, University of Washington, Seattle, Washington; and
Paul E. Christian
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Otto S. Hoekstra
4Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands
Gary S. Dorfman
7Department of Radiology, Weill Cornell Medical College, New York, New York
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 6
June 1, 2015
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra, Gary S. Dorfman
Journal of Nuclear Medicine Jun 2015, 56 (6) 955-961; DOI: 10.2967/jnumed.115.158402
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra, Gary S. Dorfman
Journal of Nuclear Medicine Jun 2015, 56 (6) 955-961; DOI: 10.2967/jnumed.115.158402
Jump to section
- Article
- Abstract
- CONTEXT OF THE IMAGING PROTOCOL WITHIN THE CLINICAL TRIAL
- SITE SELECTION, QUALIFICATION, AND TRAINING
- SUBJECT SCHEDULING
- SUBJECT PREPARATION
- IMAGING-RELATED SUBSTANCE PREPARATION AND ADMINISTRATION
- IMAGING PROCEDURE
- IMAGE POSTPROCESSING
- IMAGE ANALYSIS
- IMAGE INTERPRETATION
- ARCHIVING AND DISTRIBUTION OF DATA
- Quality Control (QC)
- IMAGING-ASSOCIATED RISKS AND RISK MANAGEMENT
- DISCLOSURE
- Acknowledgments
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
Related Articles
Cited By...
- Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
- Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
- Brown Adipose Tissue: A Protective Mechanism Against "Preprediabetes"?
- Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma
- Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
- Does PET SUV Harmonization Affect PERCIST Response Classification?
- Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
- Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- The Value of Establishing the Quantitative Accuracy of PET/CT Imaging